Resumo
Objetivo: Investigar a correlação entre os níveis séricos de ferritina e o índice de massa corporal (IMC) em pacientes obesos. Métodos: Estudo clínico, prospectivo, descritivo, tipo survey com abordagem analítica quantitativa. Foram analisados dados de 58 pacientes, com predominância do sexo feminino (65,5%) e idade média de 46,6 ± 14,1 anos. Resultados: Observou-se uma correlação positiva fraca entre IMC e ferritina (ρ = 0,387, p = 0,003). Ao estratificar a análise por sexo, observou-se uma correlação mais forte entre IMC e ferritina no sexo feminino (p= 0,3344, p=0,0401) em comparação com o sexo masculino (p=0,1263; p=0,5956), de modo que não houve significância no sexo masculino. Conclusão: Os resultados sugerem que a obesidade está associada a níveis elevados de ferritina sérica, possivelmente devido à inflamação crônica e alterações metabólicas. Essa relação pode ter implicações importantes para a avaliação do estado do ferro e risco de complicações em pacientes obesos, de modo que tal análise deve ser realizada de forma criteriosa.
Referências
AIGNER E, et al. Obesity as an emerging risk factor for iron deficiency. Revista Nutrients, 2014; 6(9): 3587-3600.
ANTUNA-PUENTE B, et al. Interleukins in adipose tissue: Keeping the balance. Revista Molecular and Cellular Endocrinology, 2022; 542: 111531.
AROSIO P, et al. Ferritin, cellular iron storage and regulation. Revista IUBMB Life, 2017; 69(6): 414-422.
BONFILS L, et al. Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study. RevistaDiabetologia. 2015; 58(3): 523-33.
CAMASCHELLA C, et al. Iron metabolism and iron disorders revisited in the hepcidin era. RevistaHaematologica, 2020; 105(2): 260-272.
CHUNG SJ, et al. Sex-Specific Associations between Serum Ferritin and Osteosarcopenic Obesity in Adults Aged over 50 Years. Rev Nutrients, 2022; 14(19): 4023.
DIGNASS A, et al. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. Revista International Journal of Chronic Diseases, 2018; 2018: 9394060.
DIGNASS AU, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis, 2015; 9(3): 211-222.
DUAN F, et al. Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction. Rev Differentiation, 2025; 141: 100832.
ENGIN A. Reappraisal of Adipose Tissue Inflammation in Obesity. Revista Advances in Experimental Medicine and Biology, 2024; 1460: 297-327.
FONSECA O, et al. New Perspectives on Circulating Ferritin: Its Role in Health and Disease. Revista Molecules, 2023; 28(23): 7707.
GANZ T e NEMETH E. Iron homeostasis in host defence and inflammation. RevNature Reviews Immunology, 2015; 15(8): 500-510.
GKOUVATSOS K, et al. Regulation of iron transport and the role of transferrin. RevistaBiochimica et Biophysica Acta, 2012; 1820(3): 188-202.
GOZZELINO R e AROSIO P. Iron Homeostasis in Health and Disease. Revista International Journal of Molecular Sciences, 2016; 17(1): 130.
LEE HS, et al. Elevated Ferritin Levels Associated with High Body Fat Mass Affect Mortality in Peritoneal Dialysis Patients. Revista Nutrients, 2023; 15(9): 2149.
MĄCZKA K, et al. The Impact of the Endocrine and Immunological Function of Adipose Tissue on Reproduction in Women with Obesity. Revista International Journal of Molecular Sciences, 2024; 25(17): 9391.
MUÑOZ MP, et al. Transferrin Saturation, Serum Ferritin, and C-Reactive Protein vs. Serum Ferritin for an optimal Iron Deficiency Diagnosis in Candidates for Bariatric Surgery. Revista Obesity Surgery, 2024; 34(4): 1174-1184.
NEMETH E e GANZ T. The role of hepcidin in iron metabolism. Revista Acta Haematologica, 2009; 122(2-3): 78-86.
OMS. Obesity and overweight. WHO Fact Sheet, 2021.
PETROVIĆ S, et al. A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases. Revista International Journal of Molecular Sciences, 2024; 25(7): 3564.
PICHÉ ME, et al. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Revista Circulation Research, 2020; 126(11): 1477-1500.
RODRÍGUEZ-MORTERA R, et al. Higher Hepcidin Levels in Adolescents with Obesity Are Associated with Metabolic Syndrome, Dyslipidemia, and Visceral Fat. Revista Antioxidants, 2021; 10(5): 751.
RUSCITTI P, et al. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications. Revista Autoimmunity Reviews, 2022; 21(7): 103114.
SCHMIDT PJ. Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation. Revista The JournalofBiologicalChemistry, 2015; 290(31): 18975-18983.
SEMENOVA Y, et al. Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders. Revista Current Medicinal Chemistry, 2024; 31(27): 4233-4248.
SIDDIQUE A, et al. Iron deficiency in patients with nonalcoholic fatty liver disease is associated with obesity, female gender, and low serum hepcidin. Revista Clinical Gastroenterology and Hepatology, 2014; 12(7): 1170-1178.
SUÁREZ-ORTEGÓN MF, et al. Both low and high body iron stores relate to metabolic syndrome in postmenopausal women: Findings from the VIKING Health Study-Shetland (VIKING I). European Journal of Clinical Investigation, 2024; 54(12): 14312.
TARANCON-DIEZ L, et al. Impact of obesity on iron metabolism and the effect of intravenous iron supplementation in obese patients with absolute iron deficiency. Revista Scientific Reports, 2025; 15(1): 1343.
TILG H, et al. Adipokines: masterminds of metabolic inflammation. Rev Nature Reviews Immunology, 2024.
ULLAH A, et al. Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases). Revista Reviews in Endocrine & Metabolic Disorders, 2024; 25(4): 783-803.
WANG W, et al. Serum ferritin: Past, present and future. Revista Biochimica et Biophysica Acta, 2010; 1800(8): 760-769.
YU PH, et al. Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations. Revista Scientific Reports, 2021; 11(1): 8343.
